What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Temperatures are rising, and the beaches, lakes, and pools are beckoning. As we head into Memorial Day weekend, the...
If you or a loved one has ever been affected by cancer, the urge to aid and provide comfort...
Twenty-three pairs of chromosomes make up the human genome of normal cells. But in 1965, researchers observed that in...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
Researchers have made great progress in understanding cancer biology and advancing the science of prevention, treatment, and survivorship. However,...
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
The story is familiar: A patient is diagnosed with cancer, they begin treatment, and, after a few months, they...
When diagnosed early, lung cancer can often be treated with surgical resection. However, patients with resectable non-small cell lung...
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
When a patient receives a cancer diagnosis, doctors may perform genetic testing to determine what drives the cancer, potentially...